Press release
Global Neutropenia Drugs Market, Size, Share, Analysis Report & Forecast to 2026
The Global neutropenia drugs market is anticipated to grow at a CAGR of 5.0% during the forecast period. The major factors for growth of the market include the increasing prevalence of cancer cases along with increasing investment in R&D by companies, to develop various novel therapies for the treatment of this disease, which will fuel the growth of the market during the forecast period.Free Sample Copy @ https://www.omrglobal.com/request-sample/neutropenia-drugs-market
Neutropenia is a disease where the number of white blood cells (neutrophils) present in the blood are reduced significantly, further hampering the immune system of the patient. In 2019, 9.8 million new cancer patients received chemotherapy treatment, according to the Lancet Oncology journal. The chemotherapy affects the count of WBCs, as some of them die during the treatment. This aspect will further grow the demand of the market during the forecast period. According to the WHO around more than 15 million patients will go under chemotherapy treatment by 2040.
A Full Report of Global Neutropenia Drugs Market is Available at:
https://www.omrglobal.com/industry-reports/neutropenia-drugs-market
According to the International Agency for Research on Cancer, in 2018, 169,270 people were living with leukemia and 58,876 new leukemia cases were diagnosed in North America. In February 2018, Partner Therapeutics, a Boston-based cancer company, acquired Leukine (Sargramostim) from Sanofi for $60 million, which is used for the treatment of leukemia. Some of the key global players in theneutropenia drugs marketinclude Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, and many others.
Global Neutropenia Drugs Market – Segmentation
By Treatment
Colony-stimulation factor
Antibiotics
Antifungal
Antiviral
By Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Neutropenia Drugs Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Teva Pharmaceutical
Amgen
Sanofi
Mylan
Kyowa Kirin
Baxter International
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neutropenia-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Neutropenia Drugs Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2428973 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Neutropenia
Global Neutropenia Market Poised for Significant Growth
Full Report: https://www.alliedmarketresearch.com/neutropenia-treatment-market-A06298
The global neutropenia market is witnessing notable expansion, driven by rising cancer prevalence, innovative treatment developments, and increasing adoption of biosimilars. According to industry reports, the market was valued at $12.6 billion in 2019 and is projected to reach $19.3 billion by 2027, growing at a CAGR of 5.4%.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A06298
Understanding Neutropenia
Neutropenia is a medical condition characterized by a deficiency of neutrophils, a…
Shaping the Neutropenia Biologic Drug Treatment Market in 2025: Advancing Neutro …
How Big Is the Neutropenia Biologic Drug Treatment Market Expected to Be, and What Will Its Growth Rate Be?
The market size for biologic drug treatment of neutropenia has seen robust growth in recent times. The market, which is projected to escalate from $13.22 billion in 2024, is expected to reach $14.08 billion in 2025, representing a compound annual growth rate (CAGR) of 6.5%. Factors such as improved market access and…
Shaping the Neutropenia Biologic Drug Treatment Market in 2025: Advancing Neutro …
How Big Is the Neutropenia Biologic Drug Treatment Market Expected to Be, and What Will Its Growth Rate Be?
The market size for biologic drug treatment of neutropenia has seen robust growth in recent times. The market, which is projected to escalate from $13.22 billion in 2024, is expected to reach $14.08 billion in 2025, representing a compound annual growth rate (CAGR) of 6.5%. Factors such as improved market access and…
Shaping the Neutropenia Biologic Drug Treatment Market in 2025: Advancing Neutro …
How Big Is the Neutropenia Biologic Drug Treatment Market Expected to Be, and What Will Its Growth Rate Be?
The market size for biologic drug treatment of neutropenia has seen robust growth in recent times. The market, which is projected to escalate from $13.22 billion in 2024, is expected to reach $14.08 billion in 2025, representing a compound annual growth rate (CAGR) of 6.5%. Factors such as improved market access and…
Biologic Drug Treatments for Neutropenia: Market Trends 2024
"The Business Research Company recently released a comprehensive report on the Global Neutropenia Biologic Drug Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
"Revolutionary Advances in Neutropenia Treatment: A Booming Market Opportunity"
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐧𝐞𝐮𝐭𝐫𝐨𝐩𝐞𝐧𝐢𝐚 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $12,602.5 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2019, 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $19,303.1 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 5.4% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.
Neutropenia is a condition characterized by a low count of neutrophils, a type of white blood cell that helps fight infections. The treatment of neutropenia depends on the underlying cause and severity of the condition. Here are some common treatments…
